Back to 
Vanguard Group Inc.
Vanguard Group Inc.
MAZE
4 quarters
Position history for Vanguard Group Inc.'s holdings in Maze Therapeutics, Inc.
As of its last 13F, for Q4 2025, Vanguard Group held 1,697,015 shares of MAZE (Maze Therapeutics), worth $70.3M. It increased the position by 362,060 shares (+27.1%) from Q3 2025. Vanguard Group held MAZE from Q1 2025 to Q4 2025, across 4 quarterly 13F filings.
Current Value
$70.3M
Current Shares
1.7M
Total Value Change
+$63M
Total Shares Change
+1M
Quarter-by-Quarter History
Other major holders of MAZE: Janus Henderson Group Ltd., BlackRock, Inc., Jupiter Topco LLC